EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Interleukin-21 receptor signaling promotes metabolic dysfunction-associated steatohepatitis-driven hepatocellular carcinoma by inducing immunosuppressive IgA+ B cells

Ying Xie, Yu Huang, Zhi-Yong Li, Weihua Jiang, Nan-Xi Shi, Yuanzhi Lu, Guangchao Cao, Zhinan Yin, Xue-Jia Lin

Molecular Cancer · 08.05.2024 · 23 (1)

DOI: 10.1186/s12943-024-02001-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Cancer, online erschienen am 08.05.2024. Verfasst von Ying Xie und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Biomedical Translational Research Institute, Key Laboratory of Viral Pathogenesis & Infection Prevention and Control, School of Medicine, Jinan U…. Hauptthemen laut MEDLINE: B-Lymphocytes, Carcinoma, Hepatocellular, Fatty Liver, Immunoglobulin A. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, 111 Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Dysregulation of immune surveillance is tightly linked to the development of metabolic dysfunction-associated steatohepatitis (MASH)-driven hepatocellular carcinoma (HCC); however, its underlying mechanisms remain unclear. Herein, we aimed to determine the role of interleukin-21 receptor (IL-21R) in MASH-driven HCC.

Methods

The clinical significance of IL-21R was assessed in human HCC specimens using immunohistochemistry staining. Furthermore, the expression of IL-21R in mice was assessed in the STAM model. Thereafter, two different MASH-driven HCC mouse models were applied between IL-21R-deficient mice and wild type controls to explore the role of IL-21R in MASH-driven HCC. To further elucidate the potential mechanisms by which IL-21R affected MASH-driven HCC, whole transcriptome sequencing, flow cytometry and adoptive lymphocyte transfer were performed. Finally, flow cytometry, enzyme-linked immunosorbent assay, immunofluorescent staining, chromatin immunoprecipitation assay and western blotting were conducted to explore the mechanism by which IL-21R induced IgA + B cells.

Results

HCC patients with high IL-21R expression exhibited poor relapse-free survival, advanced TNM stage and severe steatosis. Additionally, IL-21R was demonstrated to be upregulated in mouse liver tumors. Particularly, ablation of IL-21R impeded MASH-driven hepatocarcinogenesis with dramatically reduction of lipid accumulation. Moreover, cytotoxic CD8 + T lymphocyte activation was enhanced in the absence of IL-21R due to the reduction of immunosuppressive IgA + B cells. Mechanistically, the IL-21R-STAT1-c-Jun/c-Fos regulatory axis was activated in MASH-driven HCC and thus promoted the transcription of Igha , resulting in the induction of IgA + B cells.

Conclusions

IL-21R plays a cancer-promoting role by inducing IgA + B cells in MASH-driven hepatocarcinogenesis. Targeting IL-21R signaling represents a potential therapeutic strategy for cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

B-LymphocytesCarcinoma, HepatocellularFatty LiverImmunoglobulin ALiver NeoplasmsSignal TransductionAnimalsHumansMaleMiceCell Line, TumorDisease Models, AnimalGene Expression Regulation, NeoplasticInterleukin-21 Receptor alpha SubunitReceptors, Interleukin-21

Stichwörter der Autor:innen

Cancer-promoting roleIL-21RIgA+ B cellMASH-driven HCC

Substanzen

IL21R protein, humanImmunoglobulin AInterleukin-21 Receptor alpha SubunitReceptors, Interleukin-21Il21r protein, mouse

Autor:innen und Institutionen

  • The Biomedical Translational Research Institute, Key Laboratory of Viral Pathogenesis & Infection Prevention and Control, School of Medicine, Jinan University, Guangzhou, 510632, China.
  • Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai Institute of Translational Medicine, Zhuhai People's Hospital Affiliated With Jinan University, Jinan University, Zhuhai, 51900…
  • Department of Pathology, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, 510632, China.
  • The Biomedical Translational Research Institute, Key Laboratory of Viral Pathogenesis & Infection Prevention and Control, School of Medicine, Jinan University, Guangzhou, 510632, China. tzhinan@jnu.edu.cn.
  • The Biomedical Translational Research Institute, Key Laboratory of Viral Pathogenesis & Infection Prevention and Control, School of Medicine, Jinan University, Guangzhou, 510632, China. seta1988@126.com.

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • 111 Project
  • Tip-top Scientific and Technical Innovative Youth Talents of Guangdong Special Support Program
  • Pearl River S & T Nova Program of Guangzhou, China

Zitieren

APA

Xie, Y., Huang, Y., Li, Z. Y., Jiang, W., Shi, N. X., Lu, Y., Cao, G., Yin, Z., & Lin, X. J. (2024). Interleukin-21 receptor signaling promotes metabolic dysfunction-associated steatohepatitis-driven hepatocellular carcinoma by inducing immunosuppressive IgA+ B cells. Molecular Cancer, 23(1). https://doi.org/10.1186/s12943-024-02001-2

Vancouver

Xie Y, Huang Y, Li ZY, Jiang W, Shi NX, Lu Y, et al. Interleukin-21 receptor signaling promotes metabolic dysfunction-associated steatohepatitis-driven hepatocellular carcinoma by inducing immunosuppressive IgA+ B cells. Molecular Cancer. 2024;23(1). doi:10.1186/s12943-024-02001-2

BibTeX
@article{Xie2024,
  author = {Xie, Ying and Huang, Yu and Li, Zhi-Yong and Jiang, Weihua and Shi, Nan-Xi and Lu, Yuanzhi and Cao, Guangchao and Yin, Zhinan and Lin, Xue-Jia},
  title = {Interleukin-21 receptor signaling promotes metabolic dysfunction-associated steatohepatitis-driven hepatocellular carcinoma by inducing immunosuppressive IgA+ B cells},
  journal = {Molecular Cancer},
  year = {2024},
  volume = {23},
  number = {1},
  doi = {10.1186/s12943-024-02001-2}
}
Kostenlos starten →